Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Equity (2022 - 2025)

Atara Biotherapeutics' Return on Equity history spans 4 years, with the latest figure at 0.87% for Q4 2025.

  • For Q4 2025, Return on Equity fell 178.0% year-over-year to 0.87%; the TTM value through Dec 2025 reached 0.87%, down 178.0%, while the annual FY2025 figure was 0.48%, 8709.0% up from the prior year.
  • Return on Equity reached 0.87% in Q4 2025 per ATRA's latest filing, down from 0.66% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 13.38% in Q3 2023 to a low of 505.65% in Q1 2024.
  • Average Return on Equity over 4 years is 39.48%, with a median of 0.66% recorded in 2025.
  • Peak YoY movement for Return on Equity: crashed -50340bps in 2024, then surged 50585bps in 2025.
  • A 4-year view of Return on Equity shows it stood at 1.46% in 2022, then tumbled by -685bps to 11.42% in 2023, then skyrocketed by 108bps to 0.91% in 2024, then tumbled by -196bps to 0.87% in 2025.
  • Per Business Quant, the three most recent readings for ATRA's Return on Equity are 0.87% (Q4 2025), 0.66% (Q3 2025), and 0.13% (Q2 2025).